ALFA Finder| Value | ₹5.20 Cr |
|---|
NSE filing, NSE: GRWRHITECH. Summary written from the filing by ALFA Finder's alert engine.
Garware Hi-Tech Films Ltd: key numbers
- Share price
- ₹7,746.00
- Market cap
- ₹17,996 Cr
- Revenue (annual)
- ₹2,120 Cr
- Net profit (annual)
- ₹338.2 Cr
- P/E (TTM)
- 42.2×Sector 46.8×
- Promoter holding
- 60.72%+0.00% QoQ
- FII holding
- 4.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Garware Hi-Tech Films Ltd
All →Garware Hi-Tech Films Earnings Call Transcript: Key Takeaways
Garware delivered record quarterly revenue and EBITDA, driven by high-value architectural and paint protection films despite geopolitical headwinds. Management raised EBITDA margin guidance, signaling strong confidence in their premiumization strategy.
Garware Hi-Tech Films Investor Presentation: Key Takeaways
Garware Hi-Tech Films reported record Q2FY27 results with 22% revenue growth YoY and significant margin expansion, driven by a favorable product mix and niche specialty film focus.
- Call
- Guides 20% growth
Garware Hi-Tech Films Results Update
GHFL posted record Q2 FY27 revenue of ₹696 crore at 27.2% EBITDA margin, raising full-year guidance. H1 PAT grew 50% to ₹262 crore.
Garware Hi-Tech Films Q2 FY27 Results: Net Profit ₹129.4 Cr, Up 41.9% YoY
Garware Hi-Tech Films Ltd reported revenue from operations of ₹695.5 Cr (+22.1% YoY) and net profit of ₹129.4 Cr (+41.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹129.4 Cr · +41.9% YoY
Garware Hi-Tech Films Legal & Regulatory
MPCB forfeited a ₹25 Lakh bank guarantee from Garware Hi-Tech Films for alleged consent-condition non-compliance. The company states no material impact on business operations.
- Value
- ₹0.25 Cr
Garware Hi-Tech Films Other Announcement
The company filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026.
Other merger & restructuring announcements
All →Zydus Lifesciences Merger & Restructuring
Zydus completed its subscription for 50% of Zydus Sunshine, making it a 50:50 joint venture with Sunshine Healthcare Lanka. Completed November 11, 2026.
Spacenet Enterprises India Merger & Restructuring Worth ₹2.6 Cr
Spacenet sold 40,00,005 String Metaverse shares on 11 November 2026 at ₹6.49 each. Gross consideration of about ₹2.60 Crore is disclosed as material.
- Value
- ₹2.60 Cr
Abans Financial Services Merger & Restructuring Worth ₹1.2 Cr
Abans Financial Services approved incorporating a Hong Kong subsidiary for bullion and securities trading. The cash consideration is Rs 1.20 Crore.
- Value
- ₹1.20 Cr
Adani Enterprises Merger & Restructuring Worth ₹0.94 Cr
Adani Enterprises reported incorporation of Adani Rovuma Chemicals Limited in UAE on November 10, 2026, via Adani Global Limited. Cash consideration of Rs. 0.94 Crore was stated.
- Value
- ₹0.94 Cr
Adani Enterprises Merger & Restructuring
Adani Enterprises' subsidiary Adani Global incorporated Adani Rovuma Chemicals Limited in UAE on November 10, 2026. It is a step-down subsidiary with USD 100,000 paid-up capital.
Kovai Medical Center and Hospital Merger & Restructuring Worth ₹0.85 Cr
Kovai Medical extended the completion deadline for the slump sale of its AHS division to a related-party trust to January 31, 2027. Cash consideration is Rs.84.54 Lakhs.
- Value
- ₹0.85 Cr
- Execution
- Completion expected by 31 January 2027